Somatostatin a hasnyálmirigy betegségeinek kezelésében.

Translated title of the contribution: Somatostatin in the treatment of pancreatic diseases

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Somatostatin and its synthetic analogues have important physiological roles in human. These compounds antagonize the endocrine and exocrine secretion of pancreas, which provide theoretical ground for their use in patients with pancreatic diseases. For a quarter of a century many researchers have investigated the effect of somatostatin and octreotide in animal models of experimental pancreatitis and in patients with acute pancreatitis, and in those with complications of pancreatic operations, fistulas and pseudocysts. In most of these studies the use of synthetic octreotide with longer duration proved to be more efficient. In experimental and acute pancreatitis somatostatin and octreotide were less effective than expected, however, they proved to be helpful in preventing complications of pancreatic operations and in the therapy of fistulas and pseudocysts.

Original languageHungarian
Pages (from-to)1099-1108
Number of pages10
JournalOrvosi Hetilap
Volume143
Issue number19 Suppl
Publication statusPublished - May 12 2002

Fingerprint

Pancreatic Diseases
Octreotide
Somatostatin
Pancreatitis
Pancreatic Fistula
Pancreatic Pseudocyst
Exocrine Pancreas
Fistula
Therapeutics
Animal Models
Research Personnel

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Somatostatin a hasnyálmirigy betegségeinek kezelésében. / Németh, A.

In: Orvosi Hetilap, Vol. 143, No. 19 Suppl, 12.05.2002, p. 1099-1108.

Research output: Contribution to journalArticle

@article{7f04daa18a01423693d60fc0be766e4a,
title = "Somatostatin a hasny{\'a}lmirigy betegs{\'e}geinek kezel{\'e}s{\'e}ben.",
abstract = "Somatostatin and its synthetic analogues have important physiological roles in human. These compounds antagonize the endocrine and exocrine secretion of pancreas, which provide theoretical ground for their use in patients with pancreatic diseases. For a quarter of a century many researchers have investigated the effect of somatostatin and octreotide in animal models of experimental pancreatitis and in patients with acute pancreatitis, and in those with complications of pancreatic operations, fistulas and pseudocysts. In most of these studies the use of synthetic octreotide with longer duration proved to be more efficient. In experimental and acute pancreatitis somatostatin and octreotide were less effective than expected, however, they proved to be helpful in preventing complications of pancreatic operations and in the therapy of fistulas and pseudocysts.",
author = "A. N{\'e}meth",
year = "2002",
month = "5",
day = "12",
language = "Hungarian",
volume = "143",
pages = "1099--1108",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "19 Suppl",

}

TY - JOUR

T1 - Somatostatin a hasnyálmirigy betegségeinek kezelésében.

AU - Németh, A.

PY - 2002/5/12

Y1 - 2002/5/12

N2 - Somatostatin and its synthetic analogues have important physiological roles in human. These compounds antagonize the endocrine and exocrine secretion of pancreas, which provide theoretical ground for their use in patients with pancreatic diseases. For a quarter of a century many researchers have investigated the effect of somatostatin and octreotide in animal models of experimental pancreatitis and in patients with acute pancreatitis, and in those with complications of pancreatic operations, fistulas and pseudocysts. In most of these studies the use of synthetic octreotide with longer duration proved to be more efficient. In experimental and acute pancreatitis somatostatin and octreotide were less effective than expected, however, they proved to be helpful in preventing complications of pancreatic operations and in the therapy of fistulas and pseudocysts.

AB - Somatostatin and its synthetic analogues have important physiological roles in human. These compounds antagonize the endocrine and exocrine secretion of pancreas, which provide theoretical ground for their use in patients with pancreatic diseases. For a quarter of a century many researchers have investigated the effect of somatostatin and octreotide in animal models of experimental pancreatitis and in patients with acute pancreatitis, and in those with complications of pancreatic operations, fistulas and pseudocysts. In most of these studies the use of synthetic octreotide with longer duration proved to be more efficient. In experimental and acute pancreatitis somatostatin and octreotide were less effective than expected, however, they proved to be helpful in preventing complications of pancreatic operations and in the therapy of fistulas and pseudocysts.

UR - http://www.scopus.com/inward/record.url?scp=0037066885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037066885&partnerID=8YFLogxK

M3 - Article

C2 - 12063869

AN - SCOPUS:0037066885

VL - 143

SP - 1099

EP - 1108

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 19 Suppl

ER -